Literature DB >> 16469429

Complications of transurethral resection of the prostate (TURP)--incidence, management, and prevention.

Jens Rassweiler1, Dogu Teber, Rainer Kuntz, Rainer Hofmann.   

Abstract

OBJECTIVES: To update the complications of transurethral resection of the prostate (TURP), including management and prevention based on technological evolution.
METHODS: Based on a MEDLINE search from 1989 to 2005, the 2003 results of quality management of Baden-Württemberg, and long-term personal experience at three German centers, the incidence of complications after TURP was analyzed for three subsequent periods: early (1979-1994); intermediate (1994-1999); and recent (2000-2005) with recommendations for management and prevention.
RESULTS: Technological improvements such as microprocessor-controlled units, better armamentarium such as video TUR, and training helped to reduce perioperative complications (recent vs. early) such as transfusion rate (0.4% vs. 7.1%), TUR syndrome (0.0% vs. 1.1%), clot retention (2% vs. 5%), and urinary tract infection (1.7% vs. 8.2%). Urinary retention (3% vs. 9%) is generally attributed to primary detrusor failure rather than to incomplete resection. Early urge incontinence occurs in up to 30-40% of patients; however, late iatrogenic stress incontinence is rare (<0.5%). Despite an increasing age (55% of patients are older than 70), the associated morbidity of TURP maintained at a low level (<1%) with a mortality rate of 0-0.25%. The major late complications are urethral strictures (2.2-9.8%) and bladder neck contractures (0.3-9.2%). The retreatment rate range is 3-14.5% after five years.
CONCLUSIONS: TURP still represents the gold standard for managing benign prostatic hyperplasia with decreasing complication rates. Technological alternatives such as bipolar and laser treatments may further minimize the risks of this technically difficult procedure.

Entities:  

Mesh:

Year:  2006        PMID: 16469429     DOI: 10.1016/j.eururo.2005.12.042

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  289 in total

1.  Recent advances in the surgical treatment of benign prostatic hyperplasia.

Authors:  Bernardo Rocco; Giancarlo Albo; Rafael Coelho Ferreira; Matteo Spinelli; Gabriele Cozzi; Paolo Dell'orto; Vipul Patel; Francesco Rocco
Journal:  Ther Adv Urol       Date:  2011-12

2.  Monopolar vs. bipolar TURP: assessing their clinical advantages.

Authors:  Pierre-Alain Hueber; Ahmed Al-Asker; Kevin C Zorn
Journal:  Can Urol Assoc J       Date:  2011-12       Impact factor: 1.862

Review 3.  Laser treatment of benign prostatic hyperplasia in patients on oral anticoagulant therapy.

Authors:  Julien Berger; Gregoire Robert; Aurelien Descazeaud
Journal:  Curr Urol Rep       Date:  2010-07       Impact factor: 3.092

4.  2010 Update: Guidelines for the management of benign prostatic hyperplasia.

Authors:  J Curtis Nickel; Carlos E Méndez-Probst; Thomas F Whelan; Ryan F Paterson; Hassan Razvi
Journal:  Can Urol Assoc J       Date:  2010-10       Impact factor: 1.862

5.  Monopolar enucleation versus transurethral resection of the prostate for small- and medium-sized (< 80 cc) benign prostate hyperplasia: a prospective analysis.

Authors:  Dmitry Enikeev; Leonid Rapoport; Magomed Gazimiev; Sergey Allenov; Jasur Inoyatov; Mark Taratkin; Ekaterina Laukhtina; John M Sung; Zhamshid Okhunov; Petr Glybochko
Journal:  World J Urol       Date:  2019-04-08       Impact factor: 4.226

6.  The predictive value of platelet to lymphocyte and neutrophil to lymphocyte ratio in determining urethral stricture after transurethral resection of prostate.

Authors:  Murat Gül; Emre Altıntaş; Mehmet Kaynar; Muhammet Serdar Buğday; Serdar Göktaş
Journal:  Turk J Urol       Date:  2017-07-31

Review 7.  Meta-analysis and systematic review of intermediate-term follow-up of prostatic urethral lift for benign prostatic hyperplasia.

Authors:  Karthik Tanneru; Shiva Gautam; Daniel Norez; Jatinder Kumar; Muhammad Umar Alam; Shahriar Koocheckpour; K C Balaji; Costa Joseph
Journal:  Int Urol Nephrol       Date:  2020-02-17       Impact factor: 2.370

8.  BPH treatment: laser for everyone | Opinion: YES.

Authors:  Carlos A R Sacomani; Ricardo Vita Nunes
Journal:  Int Braz J Urol       Date:  2018 Mar-Apr       Impact factor: 1.541

9.  Day-case holmium laser enucleation of the prostate: feasibility, safety and predictive factors.

Authors:  S-M Lee; K Gordon; R McMillan; F Crystal; P Acher
Journal:  Ann R Coll Surg Engl       Date:  2018-03-15       Impact factor: 1.891

10.  Long-term results of thulium laser resection of the prostate: a prospective study at multiple centers.

Authors:  Feng Sun; Bangmin Han; Di Cui; Fujun Zhao; Xiaowen Sun; Jian Zhuo; Yifeng Jing; Haitao Liu; Shujie Xia; Yong Yang; Guangheng Luo; Fengfu Guo
Journal:  World J Urol       Date:  2014-12-09       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.